Literature DB >> 12454173

Novel single-tube agar-based test system for motility enhancement and immunocapture of Escherichia coli O157:H7 by H7 flagellar antigen-specific antibodies.

Shelton E Murinda1, Lien T Nguyen, Susan J Ivey, Raul A Almeida, Stephen P Oliver.   

Abstract

This paper describes a novel single-tube agar-based technique for motility enhancement and immunoimmobilization of Escherichia coli O157:H7. Motility indole ornithine medium and agar (0.4%, wt/vol) media containing either nutrient broth, tryptone broth, or tryptic soy broth (TSBA) were evaluated for their abilities to enhance bacterial motility. Twenty-six E. coli strains, including 19 O157:H7 strains, 1 O157:H(-) strain, and 6 generic E. coli strains, were evaluated. Test bacteria were stab inoculated in the center of the agar column, and tubes were incubated at 37 degrees C for 18 to 96 h. Nineteen to 24 of the 26 test strains (73.1 to 92.3%) were motile in the different media. TSBA medium performed best and was employed in subsequent studies of motility enhancement and H7 flagellar immunocapture. H7 flagellar antiserum (30 and 60 micro l) mixed with TSBA was placed as a band (1 ml) in the middle of an agar column separating the top (3-ml) and bottom (3-ml) agar layers. The top agar layer was inoculated with the test bacterial strains. The tubes were incubated at 37 degrees C for 12 to 18 h and for 18 to 96 h. The specificity and sensitivity of the H7 flagellar immunocapture tests were 75 and 100%, respectively. The procedure described is simple and sensitive and could be adapted easily for routine use in laboratories that do not have sophisticated equipment and resources for confirming the presence of H7 flagellar antigens. Accurate and rapid identification of H7 flagellar antigen is critical for the complete characterization of E. coli O157:H7, owing to the immense clinical, public health, and economic significance of this food-borne pathogen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454173      PMCID: PMC154605          DOI: 10.1128/JCM.40.12.4685-4690.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  A new diagnostic problem: isolation of Escherichia coli O157:H7 strains with aberrant biochemical properties.

Authors:  J M Ware; S L Abbott; J M Janda
Journal:  Diagn Microbiol Infect Dis       Date:  2000-11       Impact factor: 2.803

2.  Prevalence and molecular characterization of Escherichia coli O157:H7 in bulk tank milk and fecal samples from cull cows: a 12-month survey of dairy farms in east Tennessee.

Authors:  S E Murinda; L T Nguyen; S J Ivey; B E Gillespie; R A Almeida; F A Draughon; S P Oliver
Journal:  J Food Prot       Date:  2002-05       Impact factor: 2.077

3.  Sequence diversity of the Escherichia coli H7 fliC genes: implication for a DNA-based typing scheme for E. coli O157:H7.

Authors:  L Wang; D Rothemund; H Curd; P R Reeves
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

4.  Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli.

Authors:  E G Sowers; J G Wells; N A Strockbine
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  A multiplex polymerase chain reaction assay for rapid detection and identification of Escherichia coli O157:H7 in foods and bovine feces.

Authors:  P M Fratamico; L K Bagi; T Pepe
Journal:  J Food Prot       Date:  2000-08       Impact factor: 2.077

6.  Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM.

Authors:  P I Fields; K Blom; H J Hughes; L O Helsel; P Feng; B Swaminathan
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

7.  Monoclonal antibodies for detection of the H7 antigen of Escherichia coli.

Authors:  Y He; J E Keen; R B Westerman; E T Littledike; J Kwang
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.

Authors:  P D Fey; R S Wickert; M E Rupp; T J Safranek; S H Hinrichs
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

Review 10.  Food-related illness and death in the United States.

Authors:  P S Mead; L Slutsker; V Dietz; L F McCaig; J S Bresee; C Shapiro; P M Griffin; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more
  4 in total

1.  Identification of Cellulolytic Bacteria from Guts of Microcerotermes diversus Silvestri (Isoptera: Termitidae) in Southern Iran.

Authors:  Zeinab Fathollahi; Behzad Habibpour; Sohrab Imani; Nader Hassanzadeh; Mohammad Abdigoudarzi
Journal:  Curr Microbiol       Date:  2021-02-27       Impact factor: 2.188

2.  Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use.

Authors:  Manal A Aziz; Jaydee D Cabral; Heather J L Brooks; Stephen C Moratti; Lyall R Hanton
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

3.  Multi-metal resistance and plant growth promotion potential of a wastewater bacterium Pseudomonas aeruginosa and its synergistic benefits.

Authors:  Jayanta Kumar Biswas; Monojit Mondal; Jörg Rinklebe; Santosh Kumar Sarkar; Punarbasu Chaudhuri; Mahendra Rai; Sabry M Shaheen; Hocheol Song; Muhammad Rizwan
Journal:  Environ Geochem Health       Date:  2017-04-10       Impact factor: 4.609

4.  Characterization of virulence determinants and phylogenetic background of multiple and extensively drug resistant Escherichia coli isolated from different clinical sources in Egypt.

Authors:  Rana El-Baz; Heba Shehta Said; Eman Salama Abdelmegeed; Rasha Barwa
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-20       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.